Pancreatic Cancer

Min Li, of the University of Texas Health Sciences Health Science Center in Houston, offers dietary and lifestyle suggestions for newly diagnosed pancreatic cancer patients.

Changing the administration schedule for Gemzar (gemcitabine) plus Abraxane (nab-paclitaxel) from weekly to every other week significantly reduced side effects without impacting efficacy as a frontline treatment for patients with metastatic pancreatic cancer, according to a retrospective study presented at the 2015 GI Cancers Symposium.

An analysis of the phase 3 NAPOLI-1 trial supports the benefits of adding MM-398 chemotherapy for the treatment of patients with metastatic pancreatic cancer who were previously treated with Gemzar.

Small, yet significant, advances are reshaping pancreatic cancer treatment.

Early research shows promise in screening and detecting pancreatic cancer at its earliest stages.

When advocates unite, they can move a nation to act.

Cancer research updates from the American Society of Clinical Oncology's annual symposium on gastrointestinal cancers.

A new law hopes to boost survival in rare cancers.

Patients and families face difficult decisions when the prognosis is poor, but communication and an action plan may help.

Quality Control: Even with metastatic cancer, many patients live long and well.

The latest in cancer prevention, diagnosis, and treatment.

Information about The Pancreatic Cancer Symposia

KRAS gene mutations are detected in various cancers, including colorectal.

After a diagnosis of pancreatic cancer, this Missouri man is undaunted in efforts to connect with others.

A number of diagnostic, prognostic, or predictive tests can help determine the optimal course of treatment by using predictive markers from the patient’s or tumor’s genetic information.

Updates from the 2007 meeting of the American Society of Clinical Oncology includes news on liver, kidney, lung, colon, pancreatic and breast cancers.

The new drug for pancreatic cancer and other treatments being tested.